All Pathways
Pulmonary MedicineDiagnostic

Pleural Effusion Diagnostic and Management Algorithm (BTS 2023)

Pleural Effusion Diagnostic and Management Algorithm (BTS 2023): Pleural Effusion Identified → Clinical Assessment → Obvious Transudative Cause? → Treat...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Pleural Effusion Identified

    CXR or CT shows pleural fluid collection

    1. Action

      Clinical Assessment

      History and examination

      • Symptoms: dyspnea, pleuritic pain, cough
      • Duration and progression
      • History: HF, liver disease, malignancy, infection
      • Medications: drugs causing effusion
      • Physical exam: dullness, decreased breath sounds
      1. Decision

        Obvious Transudative Cause?

        Clinical diagnosis sufficient?

        • Bilateral effusions with heart failure
        • Known cirrhosis with ascites
        • Nephrotic syndrome
        • Typical clinical picture
        1. Action

          Treat Underlying Cause

          No diagnostic tap needed initially

          • Optimize heart failure treatment
          • Diuretics for transudate
          • Monitor response
          • Tap if no response or atypical features
          1. Action

            Diagnostic Thoracentesis

            Ultrasound-guided aspiration

            • USS guidance mandatory (BTS 2023)
            • Aspirate 20-50mL for diagnosis
            • Send: pH, protein, LDH, glucose, cytology, culture
            • Consider: Amylase, cholesterol, triglycerides, ADA
            1. Decision

              Apply Light's Criteria

              Exudate if ANY met

              • Pleural protein/serum protein >0.5
              • Pleural LDH/serum LDH >0.6
              • Pleural LDH >2/3 upper limit normal
              • EXUDATE if any positive
              1. Action

                Transudate

                Usually cardiac, hepatic, or renal cause

                • Common: Heart failure, cirrhosis, nephrotic
                • Less common: Hypothyroidism, PE, constrictive pericarditis
                • Treat underlying condition
                • Therapeutic tap if symptomatic
                1. Outcome

                  Discharge & Follow-up

                  Plan based on etiology

                  • Repeat CXR in 4-6 weeks if resolving
                  • Outpatient follow-up for ongoing management
                  • Respiratory referral for complex cases
              2. Decision

                Exudate - Further Workup

                Determine etiology

                • Infection (parapneumonic, empyema, TB)
                • Malignancy
                • Inflammatory (RA, SLE)
                • PE, pancreatitis, drugs
                1. Decision

                  Infection Markers?

                  pH, glucose, appearance

                  • pH <7.2 = Complicated parapneumonic/empyema
                  • Glucose <40 mg/dL = Complicated effusion
                  • Pus = Empyema
                  • Positive Gram stain/culture
                  1. Warning

                    Complicated Parapneumonic/Empyema

                    Requires drainage

                    • Chest drain insertion
                    • Small bore (10-14Fr) often adequate
                    • IV antibiotics
                    • Consider intrapleural fibrinolytics (tPA/DNase)
                    • Surgical referral if not improving
                  2. Action

                    Simple Parapneumonic

                    Antibiotics, monitor

                    • pH >7.2, glucose normal
                    • Antibiotics alone usually sufficient
                    • Repeat imaging in 48-72h
                    • Tap if enlarging or not improving
                2. Decision

                  Cytology/Other Tests

                  For non-infectious exudate

                  • Cytology positive = Malignant
                  • High ADA = TB consideration
                  • Chylothorax: Triglycerides >110
                  • Amylase elevated = Pancreatic/esophageal
                  1. Action

                    Malignant Pleural Effusion

                    Palliative management focus

                    • Symptom relief priority
                    • Options: Repeat aspiration, IPC, pleurodesis
                    • Indwelling pleural catheter (IPC) increasingly used
                    • Talc pleurodesis if good performance status
                    • Involve palliative care
                  2. Action

                    Undiagnosed Effusion

                    Consider further investigation

                    • CT thorax with contrast
                    • Repeat thoracentesis
                    • Thoracoscopy (VATS or medical)
                    • Pleural biopsy if TB suspected
                    • PET-CT for occult malignancy

Guideline Source

British Thoracic Society Guideline for Pleural Disease 2023

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not cover pediatric pleural effusion
  • Malignant effusion management simplified
  • Empyema staging requires clinical judgment
  • Light's criteria have known limitations

Contraindicated Populations

pediatric

Applicable Regions

UKEUGlobal

Global: Light's criteria universally applicable; local resources may vary

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Pleural Effusion Diagnostic and Management Algorithm (BTS 2023)?

The Pleural Effusion Diagnostic and Management Algorithm (BTS 2023) is a diagnostic clinical algorithm for Pulmonary Medicine. It provides a structured decision tree to guide clinical decision-making, based on British Thoracic Society Guideline for Pleural Disease 2023.

What guideline is the Pleural Effusion Diagnostic and Management Algorithm (BTS 2023) based on?

This algorithm is based on British Thoracic Society Guideline for Pleural Disease 2023 (DOI: 10.1136/thorax-2023-220304).

What are the limitations of the Pleural Effusion Diagnostic and Management Algorithm (BTS 2023)?

Known limitations include: Does not cover pediatric pleural effusion; Malignant effusion management simplified; Empyema staging requires clinical judgment; Light's criteria have known limitations. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pleural Effusion Diagnostic and Management Algorithm (BTS 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free